December 13, 2025 - 00:34

House Minority Leader Hakeem Jeffries (D-N.Y.) is set to address reporters on Friday morning following a significant setback for Democrats regarding healthcare legislation. Recently, senators voted against an attempt to extend subsidies for the Affordable Care Act (ACA), a move that has raised concerns among many regarding access to healthcare for millions of Americans.
The decision to block the extension of these subsidies comes amid ongoing discussions about healthcare reform and the future of the ACA, which has been a cornerstone of Democratic policy. Jeffries is expected to provide insight into the party's strategy moving forward, particularly in light of the critical midterm elections approaching.
In addition to healthcare issues, redistricting continues to be a contentious topic. The implications of new district maps could significantly influence the political landscape, affecting both local and national elections. Jeffries' remarks are anticipated to shed light on how Democrats plan to navigate these challenges as they seek to maintain their foothold in Congress.
December 12, 2025 - 02:10
Senate Republicans Halt Efforts to Extend Health Insurance SubsidiesOn Thursday, Senate Republicans successfully blocked a motion aimed at advancing a Democratic proposal to prolong enhanced health insurance premium subsidies, which are set to expire at the end of...
December 11, 2025 - 08:03
WHO's New Pandemic Agreement: A Step Towards Equity in Global HealthOn May 20, 2025, the World Health Assembly reached a significant milestone by unanimously adopting the World Health Organization (WHO) Pandemic Agreement, an international treaty aimed at enhancing...
December 10, 2025 - 23:09
UAMS Expands Community Health Worker Training Initiative in ArkansasLITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) Institute for Community Health Innovation is set to enhance the community health worker (CHW) workforce in Arkansas with the...
December 10, 2025 - 04:47
FDA Initiates Safety Review of RSV Medications for Infants Amid Immunization ConcernsThe Food and Drug Administration (FDA) has announced a safety review of two medications designed to combat respiratory syncytial virus (RSV) in infants. This decision comes as scrutiny increases...